Cytochrome P450 2D6 (CYP2D6) Activity Assay Kit (Fluorometric)

  • Catalog number
    K703-200
  • Price
    Please ask
  • Size
    200 assays
  • Description
    Highly Sensitive; Includes human CYP2D6 - NADPH Reductase as positive control.
  • Summary
    • Detection method - Fluorescence (Ex/Em 390/468 nm) • Species reactivity - Eukaryotes • Applications - • Rapid assessment of native/recombinant CYP2D6 activity in lysates or microsomal fractions prepared from tissues, cells. • Screening of drugs and novel ligands for interaction with native/recombinant CYP2D6.
  • Detection Method
    Fluorescence (Ex/Em 390/468 nm)
  • Species Reactivity
    Eukaryotes
  • Applications
    • Rapid assessment of native/recombinant CYP2D6 activity in lysates or microsomal fractions prepared from tissues or cells. • Screening of drugs and novel ligands for interaction with native/recombinant CYP2D6.
  • Sample Type
    • Human liver microsomes and liver S9 fractions • Lysates of tissues and cultured cells, primary hepatocytes • Heterologously expressed recombinant CYP2D6 preparations
  • Features Benefits
    • Simple, convenient, highly sensitive • Fluorescent assay enables easy determination of CYP2D6 activity in a variety of biological samples • The substrate shows low background and a high signal-to-noise ratio • Kit includes CYP2D6 inhibitor Quinidine and a stable, recombinant human CYP2D6 co-expressed with NADPH Reductase as a positive control
  • Storage Conditions
    -20°C
  • Shipping Conditions
    gel pack
  • Shelf life
    12 months
  • Background
    Cytochrome P450 2D6 (CYP2D6, EC 1.14.14.1) is a member of the cytochrome P450 monooxidase (CYP) family of microsomal xenobiotic metabolism enzymes. CYPs are membrane-bound hemeproteins responsible for Phase I biotransformation reactions, in which lipophilic drugs and other xenobiotic compounds are converted to more hydrophilic products to facilitate excretion from the body. CYP2D6 catalyzes oxidation of lipophilic bases with an aromatic ring and a nitrogen atom and is highly expressed in liver and brain tissue. The enzyme is responsible for metabolism of nearly 25% of all small molecule drugs commonly used by humans, particularly psychiatric drugs such as antidepressants, antipsychotics and stimulants. The CYP2D6 gene is highly polymorphic in the human population, with CYP2D6 activity ranging from complete metabolic deficiency to ultra-rapid metabolism. Due to this wide phenotypic variability, CYP2D6 is frequently implicated in drug toxicity and clinical drug/drug interactions. In addition, for drugs whose pharmacological activity requires metabolism from a pro-drug form, CYP2D6 inhibition or allelic deficiency can lead to decreased drug efficacy. BioVision’s CYP2D6 Activity Assay Kit enables rapid measurement of native or recombinant CYP2D6 activity in biological samples such as liver microsomes. The assay utilizes a non-fluorescent CYP2D6-selective substrate that is converted into a highly fluorescent metabolite detected in the visible range (Ex/Em = 390/468 nm), ensuring a high signal-to-background ratio with little interference by autofluorescence. CYP2D6 specific activity is calculated by running parallel reactions in the presence and absence of the potent CYP2D6-selective inhibitor quinidine and subtracting any residual activity detected with the inhibitor present. The kit contains a complete set of reagents sufficient for performing 100 sets of paired reactions (in the presence and absence of inhibitor).
  • Test
    Biovision supplies other types of Assays as 1.
  • Gene target
  • Gene symbol
    CYP2D6, CYP3A7, CYP24A1, CYP1A1, CYP51A1
  • Short name
    Cytochrome P450 2D6 (CYP2D6) Activity Assay Kit (Fluorometric)
  • Technique
    Assay, assays
  • Host
    Assay
  • Alternative name
    Cytochrome P450 2D6 (CYP2D6) Activity test reagent (fluorescence)
  • Alternative technique
    arrays, kits
  • Alternative to gene target
    v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, C-Kit and CD117 and PBT and SCFR, KIT and IDBG-18980 and ENSG00000157404 and 3815, transferase activity, Extracellular, Kit and IDBG-172083 and ENSMUSG00000005672 and 16590, KIT and IDBG-642326 and ENSBTAG00000002699 and 280832
Gene info
Gene info
Gene info
  • Identity
  • Gene
  • Long gene name
    cytochrome P450 family 24 subfamily A member 1
  • Synonyms gene
  • Synonyms gene name
    • cytochrome P450, subfamily XXIV (vitamin D 24-hydroxylase)
    • cytochrome P450, family 24, subfamily A, polypeptide 1
  • Synonyms
  • GenBank acession
  • Locus
  • Discovery year
    1992-09-09
  • Entrez gene record
  • Classification
    • Cytochrome P450 family 24
  • VEGA ID
Gene info
Gene info
  • Identity
  • Gene
  • Long gene name
    cytochrome P450 family 51 subfamily A member 1
  • Synonyms gene
  • Synonyms gene name
    • cytochrome P450, 51 (lanosterol 14-alpha-demethylase)
    • cytochrome P450, family 51, subfamily A, polypeptide 1
  • Synonyms
  • GenBank acession
  • Locus
  • Discovery year
    1996-10-26
  • Entrez gene record
  • Pubmed identfication
  • Classification
    • Cytochrome P450 family 51
  • VEGA ID
MeSH Data
  • Name
  • Concept
    Scope note: Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels.
  • Tree numbers
    • E05.196.401.250
    • E05.301.300.230
  • Qualifiers
    ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee